Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy (Q38457311)

3 September 2017

title

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy (English)

1 reference

3 September 2017

main subject

anti-retroviral agent

0 references

E Lanoy

0 references

Aba Mahamat

object named as

A Mahamat

0 references

Dominique Costagliola

D Costagliola

0 references

S Grabar

1 reference

3 September 2017

C Allavena

1 reference

3 September 2017

M Mary-Krause

1 reference

3 September 2017

M Bentata

1 reference

3 September 2017

P Fischer

1 reference

3 September 2017

C Rabaud

1 reference

3 September 2017

Clinical Epidemiology Group of the French Hospital Database on HIV

1 reference

3 September 2017

publication date

1 April 2008

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

1 reference

3 September 2017

page(s)

246-256

1 reference

Survival of AIDS patients according to type of AIDS-defining event. The AIDS in Europe Study Group

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Record-linkage between two anonymous databases for a capture-recapture estimation of underreporting of AIDS cases: France 1990-1993. The Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

A note on competing risks in survival data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Trends in AIDS and mortality in HIV-infected subjects with hemophilia from 1985 to 2003: the competing risks for death between AIDS and liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

A Proportional Hazards Model for the Subdistribution of a Competing Risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

Improving estimates of event incidence over time in populations exposed to other events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00554.X

10.1111/J.1468-1293.2008.00554.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference